The Center for the Evaluation of Vaccination (UA-CEV) of the University of Antwerp, headed by Prof. Pierre Van Damme, was founded in 1994. It has until present conducted more than 450 vaccine trials (phase 1-4) with a variety of vaccines and in all age groups. Furthermore, CEV has conducted more than 60 policy research projects related to vaccination. It has published more than 500 peer reviewed papers. The Center has been recognised by the World Health Organization as a WHO Collaborating Center for the control and prevention of viral hepatitis and more recently for the control and prevention of infectious diseases. CEV provides state-of-the-art infrastructure for the conduct of vaccine studies. The research mission of CEV is to improve knowledge on all aspects of vaccination (including education) and to support vaccination policy making.
Main roles in project
The Center will be responsible for the conduct of a first in man trial to establish the safety and immune profile of the experimental COBRA vaccine. In addition, the Center will participate in the conduct of a phase IV trial to test the seasonal flu vaccine in vulnerable patients (elderly). CEV will also contribute to the management and coordination of the consortium as a work package leader.
Contact: Prof. Pierre Van Damme
This project has received funding from the European Union H2020 (grant no. 874866) and the Dept. of Biotechnology, Govt. of India (project no. BT/IN/EU-INF/16/AP/19-20/11746)